Published in Mol Cell Biol on August 01, 2003
Dorsal-ventral patterning and neural induction in Xenopus embryos. Annu Rev Cell Dev Biol (2004) 3.96
The BMP-binding protein Crossveinless 2 is a short-range, concentration-dependent, biphasic modulator of BMP signaling in Drosophila. Dev Cell (2008) 2.17
Rare copy number variants disrupt genes regulating vascular smooth muscle cell adhesion and contractility in sporadic thoracic aortic aneurysms and dissections. Am J Hum Genet (2010) 2.07
The extracellular regulation of bone morphogenetic protein signaling. Development (2009) 1.69
Crossveinless-2 Is a BMP feedback inhibitor that binds Chordin/BMP to regulate Xenopus embryonic patterning. Dev Cell (2008) 1.69
Bone morphogenetic protein endothelial cell precursor-derived regulator regulates retinal angiogenesis in vivo in a mouse model of oxygen-induced retinopathy. Arterioscler Thromb Vasc Biol (2011) 1.56
Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. J Cancer Res Clin Oncol (2005) 1.55
Dlx genes pattern mammalian jaw primordium by regulating both lower jaw-specific and upper jaw-specific genetic programs. Development (2008) 1.46
A concentration-dependent endocytic trap and sink mechanism converts Bmper from an activator to an inhibitor of Bmp signaling. J Cell Biol (2009) 1.39
The FoxO family in cardiac function and dysfunction. Annu Rev Physiol (2010) 1.33
CCN6 modulates BMP signaling via the Smad-independent TAK1/p38 pathway, acting to suppress metastasis of breast cancer. Cancer Res (2012) 1.22
ASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanism. Mol Cell Biol (2007) 1.17
BMPER is a conserved regulator of hematopoietic and vascular development in zebrafish. J Mol Cell Cardiol (2007) 1.17
Gene expression profiles identify a role for cyclooxygenase 2-dependent prostanoid generation in BMP6-induced angiogenic responses. Blood (2007) 1.16
Development of the vertebral morphogenetic field in the mouse: interactions between Crossveinless-2 and Twisted Gastrulation. Dev Biol (2008) 1.15
Gene expression profiling to identify eggshell proteins involved in physical defense of the chicken egg. BMC Genomics (2010) 1.15
Crossveinless 2 regulates bone morphogenetic protein 9 in human and mouse vascular endothelium. Blood (2012) 1.05
Vessel formation is induced prior to the appearance of cartilage in BMP-2-mediated heterotopic ossification. J Bone Miner Res (2010) 1.03
The opening act: vasculogenesis and the origins of circulation. Arterioscler Thromb Vasc Biol (2008) 1.03
Hemodynamic forces, vascular oxidative stress, and regulation of BMP-2/4 expression. Antioxid Redox Signal (2009) 1.02
LRP1-dependent endocytic mechanism governs the signaling output of the bmp system in endothelial cells and in angiogenesis. Circ Res (2012) 0.99
Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture. Stem Cell Reports (2014) 0.98
dlx3b/4b are required for the formation of the preplacodal region and otic placode through local modulation of BMP activity. Dev Biol (2008) 0.96
Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy. Exp Eye Res (2014) 0.93
Mouse lysocardiolipin acyltransferase controls the development of hematopoietic and endothelial lineages during in vitro embryonic stem-cell differentiation. Blood (2007) 0.93
PRDM6 is enriched in vascular precursors during development and inhibits endothelial cell proliferation, survival, and differentiation. J Mol Cell Cardiol (2007) 0.92
BMPER is upregulated by statins and modulates endothelial inflammation by intercellular adhesion molecule-1. Arterioscler Thromb Vasc Biol (2009) 0.92
Mesendodermal signals required for otic induction: Bmp-antagonists cooperate with Fgf and can facilitate formation of ectopic otic tissue. Dev Dyn (2009) 0.92
Bone morphogenetic protein modulator BMPER is highly expressed in malignant tumors and controls invasive cell behavior. Oncogene (2011) 0.92
New insights into bone morphogenetic protein signaling: focus on angiogenesis. Curr Opin Hematol (2009) 0.91
Gene expression programs of mouse endothelial cells in kidney development and disease. PLoS One (2010) 0.90
Bmper inhibits endothelial expression of inflammatory adhesion molecules and protects against atherosclerosis. Arterioscler Thromb Vasc Biol (2012) 0.88
Bone Morphogenetic Protein functions as a context-dependent angiogenic cue in vertebrates. Semin Cell Dev Biol (2011) 0.88
Endothelial cells in co-culture enhance embryonic stem cell differentiation to pancreatic progenitors and insulin-producing cells through BMP signaling. Stem Cell Rev (2011) 0.88
BMPER-induced BMP signaling promotes coronary artery remodeling. Dev Biol (2013) 0.87
Life is a pattern: vascular assembly within the embryo. Front Biosci (Elite Ed) (2012) 0.86
In vitro and In vivo imaging of antivasculogenesis induced by Noggin protein expression in human venous endothelial cells. FASEB J (2009) 0.85
BMPER protein is a negative regulator of hepcidin and is up-regulated in hypotransferrinemic mice. J Biol Chem (2011) 0.85
Krüppel-like factor 15 regulates BMPER in endothelial cells. Cardiovasc Res (2009) 0.84
Osteoblast-like differentiation of cultured human coronary artery smooth muscle cells by bone morphogenetic protein endothelial cell precursor-derived regulator (BMPER). J Biol Chem (2012) 0.83
Impaired resolution of inflammation in the Endoglin heterozygous mouse model of chronic colitis. Mediators Inflamm (2014) 0.83
Coevolutionary patterning of teeth and taste buds. Proc Natl Acad Sci U S A (2015) 0.83
LRP1 Regulates Retinal Angiogenesis by Inhibiting PARP-1 Activity and Endothelial Cell Proliferation. Arterioscler Thromb Vasc Biol (2015) 0.82
Crossveinless-2 controls bone morphogenetic protein signaling during early cardiomyocyte differentiation in P19 cells. J Biol Chem (2008) 0.81
PGE2 through the EP4 receptor controls smooth muscle gene expression patterns in the ductus arteriosus critical for remodeling at birth. Prostaglandins Other Lipid Mediat (2012) 0.81
BMPER regulates cardiomyocyte size and vessel density in vivo. Cardiovasc Pathol (2012) 0.80
The ubiquitin ligase ASB4 promotes trophoblast differentiation through the degradation of ID2. PLoS One (2014) 0.80
Development of anaplastic Wilms tumor and subsequent relapse in a child with diaphanospondylodysostosis. J Pediatr Hematol Oncol (2012) 0.80
PreImplantation factor (PIF*) promotes embryotrophic and neuroprotective decidual genes: effect negated by epidermal growth factor. J Neurodev Disord (2014) 0.79
Bone morphogenetic protein-4: a novel therapeutic target for pathological cardiac hypertrophy/heart failure. Heart Fail Rev (2014) 0.79
Spatio-Temporal Gene Expression Profiling during In Vivo Early Ovarian Folliculogenesis: Integrated Transcriptomic Study and Molecular Signature of Early Follicular Growth. PLoS One (2015) 0.77
Methylation-mediated BMPER expression in fibroblast activation in vitro and lung fibrosis in mice in vivo. Sci Rep (2015) 0.77
Fibroblast growth factor signalling controls nervous system patterning and pigment cell formation in Ciona intestinalis. Nat Commun (2014) 0.77
Involvement of Rho-associated protein kinase (ROCK) and bone morphogenetic protein-binding endothelial cell precursor-derived regulator (BMPER) in high glucose-increased alkaline phosphatase expression and activity in human coronary artery smooth muscle cells. Cardiovasc Diabetol (2015) 0.76
Bone Morphogenetic Protein-Modulator BMPER Regulates Endothelial Barrier Function. Inflammation (2017) 0.76
Expression Profiles of TGF-β and TLR Pathways in Porphyromonas gingivalis and Prevotella intermedia Challenged Osteoblasts. Jundishapur J Microbiol (2015) 0.75
BMPER Promotes Epithelial-Mesenchymal Transition in the Developing Cardiac Cushions. PLoS One (2015) 0.75
Bone morphogenetic protein-binding endothelial regulator of liver sinusoidal endothelial cells induces iron overload in a fatty liver mouse model. J Gastroenterol (2016) 0.75
LRP1-Dependent BMPER Signaling Regulates Lipopolysaccharide-Induced Vascular Inflammation. Arterioscler Thromb Vasc Biol (2017) 0.75
Combined Effects of Bone Morphogenetic Protein 10 and Crossveinless-2 on Cardiomyocyte Differentiation in Mouse Adipocyte-Derived Stem Cells. J Cell Physiol (2017) 0.75
Coronary Artery Development: Progenitor Cells and Differentiation Pathways. Annu Rev Physiol (2016) 0.75
Low-Density Lipoprotein Receptor-Related Protein-1 Signaling in Angiogenesis. Front Cardiovasc Med (2017) 0.75
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature (1995) 15.15
Bone: formation by autoinduction. Science (1965) 13.34
TGFbeta signaling in growth control, cancer, and heritable disorders. Cell (2000) 12.38
Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature (2000) 7.15
Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev (1995) 7.13
Definitive hematopoiesis is autonomously initiated by the AGM region. Cell (1996) 5.75
Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell (1992) 5.31
Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes. Cell (1994) 4.53
Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev (1995) 4.23
Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol (2002) 4.14
Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A (2000) 4.08
Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development (1996) 3.91
Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell (1996) 3.91
flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development (1993) 3.66
Expression of a Xenopus homolog of Brachyury (T) is an immediate-early response to mesoderm induction. Cell (1991) 3.40
Alternative neural crest cell fates are instructively promoted by TGFbeta superfamily members. Cell (1996) 3.39
Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev (1999) 3.35
Molecular nature of Spemann's organizer: the role of the Xenopus homeobox gene goosecoid. Cell (1991) 3.23
Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol (2002) 3.13
Follistatin, an antagonist of activin, is expressed in the Spemann organizer and displays direct neuralizing activity. Cell (1994) 2.98
Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood (2000) 2.98
Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood (1996) 2.94
The entire mesodermal mantle behaves as Spemann's organizer in dorsoanterior enhanced Xenopus laevis embryos. Dev Biol (1988) 2.79
In vitro generation of lymphohematopoietic cells from endothelial cells purified from murine embryos. Immunity (1998) 2.54
Twisted gastrulation is a conserved extracellular BMP antagonist. Nature (2001) 2.50
Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology (2002) 2.49
DVR-4 (bone morphogenetic protein-4) as a posterior-ventralizing factor in Xenopus mesoderm induction. Development (1992) 2.38
Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development (1999) 2.35
Indian hedgehog activates hematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in the mouse embryo. Development (2001) 2.33
Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development (1997) 2.32
Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency. Science (1997) 2.28
Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci U S A (2002) 2.27
Bone morphogenetic protein 4: a ventralizing factor in early Xenopus development. Development (1992) 2.19
Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-beta1 and BMP-2. J Cell Biol (1999) 2.17
Secreted noggin protein mimics the Spemann organizer in dorsalizing Xenopus mesoderm. Nature (1993) 2.02
BMP-binding modules in chordin: a model for signalling regulation in the extracellular space. Development (2000) 2.02
An early pre-liver intraembryonic source of CFU-S in the developing mouse. Nature (1993) 2.01
Localized enhancement and repression of the activity of the TGF-beta family member, decapentaplegic, is necessary for dorsal-ventral pattern formation in the Drosophila embryo. Development (1992) 1.95
Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. Dev Biol (2001) 1.90
Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. J Biol Chem (2000) 1.87
Proteolytic cleavage of Chordin as a switch for the dual activities of Twisted gastrulation in BMP signaling. Development (2001) 1.86
Crossveinless 2 contains cysteine-rich domains and is required for high levels of BMP-like activity during the formation of the cross veins in Drosophila. Development (2000) 1.82
Coordinate expression of Fgf8, Otx2, Bmp4, and Shh in the rostral prosencephalon during development of the telencephalic and optic vesicles. Neuroscience (2001) 1.82
Hedgehog is required for murine yolk sac angiogenesis. Development (2002) 1.82
Embryonic stem cell-derived cystic embryoid bodies form vascular channels: an in vitro model of blood vessel development. Development (1992) 1.77
Antagonizing the Spemann organizer: role of the homeobox gene Xvent-1. EMBO J (1995) 1.69
Mix.1, a homeobox mRNA inducible by mesoderm inducers, is expressed mostly in the presumptive endodermal cells of Xenopus embryos. Cell (1989) 1.67
An SCL 3' enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors. Development (1999) 1.67
Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Dev (2003) 1.62
Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo. Dev Biol (1991) 1.56
Dorsalization and neural induction: properties of the organizer in Xenopus laevis. J Embryol Exp Morphol (1983) 1.55
The role of BMP-4 and GATA-2 in the induction and differentiation of hematopoietic mesoderm in Xenopus laevis. Blood (1996) 1.37
The BMP/BMPR/Smad pathway directs expression of the erythroid-specific EKLF and GATA1 transcription factors during embryoid body differentiation in serum-free media. Development (2002) 1.30
Adult and embryonic blood and endothelium derive from distinct precursor populations which are differentially programmed by BMP in Xenopus. Development (2002) 1.28
Cloning and expression of a cDNA encoding mouse endoglin, an endothelial cell TGF-beta ligand. Gene (1994) 1.23
Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells. Endocrinology (1994) 1.21
Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells. J Biol Chem (2002) 1.20
A novel chordin-like protein inhibitor for bone morphogenetic proteins expressed preferentially in mesenchymal cell lineages. Dev Biol (2001) 1.19
The roles of three signaling pathways in the formation and function of the Spemann Organizer. Development (2002) 1.15
Endoglin expression in early development is associated with vasculogenesis and angiogenesis. Mech Dev (2002) 1.07
Nonradioactive in situ hybridization to xenopus tissue sections. Methods (2001) 1.06
Xenopus kielin: A dorsalizing factor containing multiple chordin-type repeats secreted from the embryonic midline. Proc Natl Acad Sci U S A (2000) 1.04
Endothelial cell origin and migration in embryonic heart and cranial blood vessel development. Anat Rec (1991) 1.03
Neuralin-1 is a novel Chordin-related molecule expressed in the mouse neural plate. Mech Dev (2001) 1.02
Is chordin a long-range- or short-range-acting factor? Roles for BMP1-related metalloproteases in chordin and BMP4 autofeedback loop regulation. Dev Biol (2000) 0.94
A complex linkage in the developmental pathway of endothelial and hematopoietic cells. Curr Opin Cell Biol (2001) 0.94
Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor. Blood (2000) 0.91
Embryonic stem cell differentiation and the vascular lineage. Methods Mol Biol (2002) 0.87
A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization. Blood (1998) 0.81
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet (2005) 17.07
Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med (2011) 7.30
Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med (2006) 5.39
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med (2006) 5.07
Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci U S A (2008) 4.00
Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell (2006) 3.73
Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu. Proc Natl Acad Sci U S A (2002) 3.54
Proteotoxicity and cardiac dysfunction--Alzheimer's disease of the heart? N Engl J Med (2013) 3.41
The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J Clin Invest (2007) 3.35
Effect of Availability of Transcatheter Aortic-Valve Replacement on Clinical Practice. N Engl J Med (2015) 3.29
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med (2011) 3.20
Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest (2004) 3.09
Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J (2003) 3.06
Protein quality control: U-box-containing E3 ubiquitin ligases join the fold. Trends Biochem Sci (2002) 3.01
CHIP: a link between the chaperone and proteasome systems. Cell Stress Chaperones (2003) 2.98
CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70. Nature (2006) 2.90
The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab (2007) 2.84
CHIP activates HSF1 and confers protection against apoptosis and cellular stress. EMBO J (2003) 2.78
The western clawed frog (Xenopus tropicalis): an emerging vertebrate model for developmental genetics and environmental toxicology. Cold Spring Harb Protoc (2009) 2.64
Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation (2008) 2.59
Early versus delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med (2009) 2.49
T-box genes in early embryogenesis. Dev Dyn (2004) 2.45
Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. Proc Natl Acad Sci U S A (2004) 2.34
Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins. J Clin Invest (2007) 2.25
Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy. EMBO J (2002) 2.17
The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis. Blood (2004) 2.07
Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo. Circ Res (2007) 2.05
A sonic hedgehog signaling domain in the arterial adventitia supports resident Sca1+ smooth muscle progenitor cells. Proc Natl Acad Sci U S A (2008) 2.05
Tbx5 and Tbx20 act synergistically to control vertebrate heart morphogenesis. Development (2005) 2.02
Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species. J Neurosci (2006) 1.98
Myocardial lineage development. Circ Res (2010) 1.98
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. Int J Cardiol (2013) 1.95
Mitochondrial integrity and function in atherogenesis. Circulation (2002) 1.94
ERK signaling is a central regulator for BMP-4 dependent capillary sprouting. Cardiovasc Res (2007) 1.90
Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death. J Am Coll Cardiol (2004) 1.88
Adenosine produces nitric oxide and prevents mitochondrial oxidant damage in rat cardiomyocytes. Cardiovasc Res (2005) 1.87
The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways. J Biol Chem (2005) 1.85
Differential activation of mitogenic signaling pathways in aortic smooth muscle cells deficient in superoxide dismutase isoforms. Arterioscler Thromb Vasc Biol (2005) 1.84
The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. J Cell Biol (2008) 1.82
CHIP deficiency decreases longevity, with accelerated aging phenotypes accompanied by altered protein quality control. Mol Cell Biol (2008) 1.82
Natural mating and tadpole husbandry in the western clawed frog Xenopus tropicalis. Cold Spring Harb Protoc (2009) 1.80
Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease. Circ Res (2010) 1.78
A critical role for muscle ring finger-1 in acute lung injury-associated skeletal muscle wasting. Am J Respir Crit Care Med (2012) 1.74
Local guidance of emerging vessel sprouts requires soluble Flt-1. Dev Cell (2009) 1.72
Increased levels of circulating microparticles in patients with severe aortic valve stenosis. Thromb Haemost (2008) 1.70
A foldable CFTR{Delta}F508 biogenic intermediate accumulates upon inhibition of the Hsc70-CHIP E3 ubiquitin ligase. J Cell Biol (2004) 1.70
Perturbation of the endothelial glycocalyx in post cardiac arrest syndrome. Resuscitation (2012) 1.69
The T-box family. Genome Biol (2002) 1.69
Egg collection and in vitro fertilization of the western clawed frog Xenopus tropicalis. Cold Spring Harb Protoc (2009) 1.68
Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol Biol Cell (2003) 1.67
Non-invasive imaging in the diagnosis of acute viral myocarditis. Clin Res Cardiol (2009) 1.66
Akt and CHIP coregulate tau degradation through coordinated interactions. Proc Natl Acad Sci U S A (2008) 1.66
CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity. Proc Natl Acad Sci U S A (2009) 1.64
Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial. Circulation (2005) 1.64
Chaperone functions of the E3 ubiquitin ligase CHIP. J Biol Chem (2007) 1.63
CD40L induces inflammation and adipogenesis in adipose cells--a potential link between metabolic and cardiovascular disease. Thromb Haemost (2010) 1.63
Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy. J Cell Biol (2004) 1.62
Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation. Blood (2006) 1.62
The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. Am J Pathol (2004) 1.61
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone. Am J Cardiol (2002) 1.60
CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler Thromb Vasc Biol (2007) 1.59
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial. JACC Cardiovasc Interv (2009) 1.56
Bone morphogenetic protein endothelial cell precursor-derived regulator regulates retinal angiogenesis in vivo in a mouse model of oxygen-induced retinopathy. Arterioscler Thromb Vasc Biol (2011) 1.56
CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation. J Biol Chem (2006) 1.55
Sequential roles for myosin-X in BMP6-dependent filopodial extension, migration, and activation of BMP receptors. J Cell Biol (2007) 1.54
Thrombolysis during resuscitation for out-of-hospital cardiac arrest. N Engl J Med (2008) 1.54
Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial. J Am Coll Cardiol (2010) 1.54
Focal adhesion kinase is essential for cardiac looping and multichamber heart formation. Genesis (2010) 1.51
Pacemaker therapy in very elderly patients: long-term survival and prognostic parameters. Am Heart J (2003) 1.51
Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits. Heart Rhythm (2013) 1.50
Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division. Blood (2002) 1.48
BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis. Circ Res (2008) 1.48
Regulation of the cytoplasmic quality control protein degradation pathway by BAG2. J Biol Chem (2005) 1.46
Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial. JAMA (2013) 1.45
Distinct signalling pathways regulate sprouting angiogenesis from the dorsal aorta and the axial vein. Nat Cell Biol (2011) 1.43
CHIP, a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice. Am J Physiol Heart Circ Physiol (2005) 1.43
Build it up-Tear it down: protein quality control in the cardiac sarcomere. Cardiovasc Res (2008) 1.42
Arteriogenesis - is this terminology necessary? Basic Res Cardiol (2003) 1.41
A concentration-dependent endocytic trap and sink mechanism converts Bmper from an activator to an inhibitor of Bmp signaling. J Cell Biol (2009) 1.39
Blood pressure-associated polymorphism controls ARHGAP42 expression via serum response factor DNA binding. J Clin Invest (2017) 1.38
Differential effects of the β-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels. J Cardiovasc Electrophysiol (2013) 1.38
Mortality in patients with atrial fibrillation has significantly decreased during the last three decades: 35 years of follow-up in 1627 pacemaker patients. Europace (2008) 1.38
Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets. Circ Res (2006) 1.38
MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells. Circulation (2011) 1.38
An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP). J Biol Chem (2004) 1.36
Into the heart: the emerging role of the ubiquitin-proteasome system. J Mol Cell Cardiol (2006) 1.35
CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation (2007) 1.35